{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:54:57Z","timestamp":1791248097973,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T00:00:00Z","timestamp":1172793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T00:00:00Z","timestamp":1172793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s10620-006-9119-z","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T01:57:54Z","timestamp":1172800674000},"page":"1262-1269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Thiopurine Methyltransferase Activity in Spain: A Study of 14,545 Patients"],"prefix":"10.1007","volume":"52","author":[{"given":"Javier P.","family":"Gisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago","family":"Gonz\u00e1lez-Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Pajares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,2]]},"reference":[{"key":"9119_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/s-2002-35706","volume":"22","author":"AJ Czaja","year":"2002","unstructured":"Czaja, AJ (2002) Treatment of autoimmune hepatitis. Semin Liver Dis 22:365\u2013378","journal-title":"Semin Liver Dis"},{"key":"9119_CR2","unstructured":"Sandborn, W, Sutherland, L, Pearson, D, May, G, Modigliani, R, Prantera, C (2000) Azathioprine or 6-mercaptopurine for inducing remission of Crohn\u2019s disease. Cochrane, Database Syst, Rev CD000545"},{"key":"9119_CR3","unstructured":"Pearson, DC, May, GR, Fick, G, Sutherland, LR (2000) Azathioprine for maintaining remission of Crohn\u2019s disease. Cochrane, Database Syst, Rev CD000067"},{"key":"9119_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2004.04.016","volume":"223","author":"O Fernandez","year":"2004","unstructured":"Fernandez, O, Fernandez, V, DeRamon, E (2004) Azathioprine and methotrexate in multiple sclerosis. J Neurol Sci 223:29\u201334","journal-title":"J Neurol Sci"},{"key":"9119_CR5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0014-2565(02)71143-0","volume":"202","author":"JP Gisbert","year":"2002","unstructured":"Gisbert, JP, Gomollon, F, Mate, J, Pajares, JM (2002) Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity. Rev Clin Esp 202:555\u2013562","journal-title":"Rev Clin Esp"},{"key":"9119_CR6","first-page":"738","volume":"34","author":"DM Tidd","year":"1974","unstructured":"Tidd, DM, Paterson, AR (1974) A biochemical mechanism for the delayed cytotoxic reaction of 6- mercaptopurine. Cancer Res 34:738\u2013746","journal-title":"Cancer Res"},{"key":"9119_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/clpt.1989.119","volume":"46","author":"L Lennard","year":"1989","unstructured":"Lennard, L, VanLoon, JA, Weinshilboum, RM (1989) Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 46:149\u2013154","journal-title":"Clin Pharmacol Ther"},{"key":"9119_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","volume":"118","author":"MC Dubinsky","year":"2000","unstructured":"Dubinsky, MC, Lamothe, S, Yang, HY, Targan, SR, Sinnett, D, Theoret, Y, et\u00a0al (2000) Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 118:705\u2013713","journal-title":"Gastroenterology"},{"key":"9119_CR9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/014107689208501213","volume":"85","author":"A Anstey","year":"1992","unstructured":"Anstey, A, Lennard, L, Mayou, SC, Kirby, JD: Pancytopenia related to azathioprine\u2014an enzyme deficiency caused by a common genetic polymorphism (1992) a review. J R Soc Med 85:752\u2013756","journal-title":"J R Soc Med"},{"key":"9119_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/gut.49.5.665","volume":"49","author":"PW Lowry","year":"2001","unstructured":"Lowry, PW, Franklin, CL, Weaver, AL, Gennett Pike, M, Mays, DC, Tremaine, WJ, et\u00a0al. (2001) Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut 49:665\u2013670","journal-title":"Gut"},{"key":"9119_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2125.1999.00884.x","volume":"47","author":"L Lennard","year":"1999","unstructured":"Lennard, L (1999) Therapeutic drug monitoring of antimetabolic cytotoxic drugs. Br J Clin Pharmacol 47:131\u2013143","journal-title":"Br J Clin Pharmacol"},{"key":"9119_CR12","first-page":"651","volume":"32","author":"RM Weinshilboum","year":"1980","unstructured":"Weinshilboum, RM, Sladek, SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651\u2013662","journal-title":"Am J Hum Genet"},{"key":"9119_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1191\/1352458502ms796oa","volume":"8","author":"C Menor","year":"2002","unstructured":"Menor, C, Fueyo, J, Escribano, O, Pina, MJ, Redondo, P, Cara, C, et\u00a0al. (2002) Thiopurine methyltransferase activity in a Spanish population sample: decrease of enzymatic activity in multiple sclerosis patients. Mult Scler 8:243\u2013248","journal-title":"Mult Scler"},{"key":"9119_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00045391-200105000-00002","volume":"8","author":"G Decaux","year":"2001","unstructured":"Decaux, G, Horsmans, Y, Houssiau, F, Desager, JP (2001) High 6-thioguanine nucleotide levels and low thiopurine methyltransferase activity in patients with lupus erythematosus treated with azathioprine. Am J Ther 8:147\u2013150","journal-title":"Am J Ther"},{"key":"9119_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00007691-200110000-00007","volume":"23","author":"C Menor","year":"2001","unstructured":"Menor, C, Fueyo, JA, Escribano, O, Cara, C, Fernandez-Moreno, MD, Roman, ID, et\u00a0al. (2001) Determination of thiopurine methyltransferase activity in human erythrocytes by high-performance liquid chromatography: comparison with the radiochemical method. Ther Drug Monit 23:536\u2013541","journal-title":"Ther Drug Monit"},{"key":"9119_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/archderm.131.2.193","volume":"131","author":"JL Snow","year":"1995","unstructured":"Snow, JL, Gibson, LE (1995) The role of genetic variation in thiopurine methyltransferase activity and the efficacy and\/or side effects of azathioprine therapy in dermatologic patients. Arch Dermatol 131:193\u2013197","journal-title":"Arch Dermatol"},{"key":"9119_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s002280100267","volume":"57","author":"A Lowenthal","year":"2001","unstructured":"Lowenthal, A, Meyerstein, N, Ben-Zvi, Z (2001) Thiopurine methyltransferase activity in the Jewish population of Israel. Eur J Clin Pharmacol 57:43\u201346","journal-title":"Eur J Clin Pharmacol"},{"key":"9119_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.bjp.0702152","volume":"125","author":"C Spire-Vayron de la Moureyre","year":"1998","unstructured":"Spire-Vayron de la Moureyre, C, Debuysere, H, Mastain, B, Vinner, E, Marez, D, Lo Guidice, JM, et\u00a0al. (1998) Genotypic and phenotypic analysis of the polymorphic thiopurine S- methyltransferase gene (TPMT) in a European population. Br J Pharmacol 125:879\u2013887","journal-title":"Br J Pharmacol"},{"key":"9119_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0009-9236(96)90169-1","volume":"60","author":"JO Park-Hah","year":"1996","unstructured":"Park-Hah, JO, Klemetsdal, B, Lysaa, R, Choi, KH, Aarbakke, J (1996) Thiopurine methyltransferase activity in a Korean population sample of children. Clin Pharmacol Ther 60:68\u201374","journal-title":"Clin Pharmacol Ther"},{"key":"9119_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s002280050457","volume":"54","author":"T Kroplin","year":"1998","unstructured":"Kroplin, T, Weyer, N, Gutsche, S, Iven, H (1998) Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 54:265\u2013271","journal-title":"Eur J Clin Pharmacol"},{"key":"9119_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/00008571-199208000-00002","volume":"2","author":"CL Szumlanski","year":"1992","unstructured":"Szumlanski, CL, Honchel, R, Scott, MC, Weinshilboum, RM (1992) Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics 2:148\u2013159","journal-title":"Pharmacogenetics"},{"key":"9119_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1365-2036.2002.01177.x","volume":"16","author":"S Campbell","year":"2002","unstructured":"Campbell, S, Kingstone, K, Ghosh, S (2002) Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine. Aliment Pharmacol Ther 16:389\u2013398","journal-title":"Aliment Pharmacol Ther"},{"key":"9119_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1157\/13048470","volume":"121","author":"JP Gisbert","year":"2003","unstructured":"Gisbert, JP, Luna, M, Mate, J, Gonzalez-Guijarro, L, Cara, C, Pajares, JM (2003) Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Med Clin (Barc) 121:1\u20135","journal-title":"Med Clin (Barc)"},{"key":"9119_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00007890-199510150-00003","volume":"60","author":"J Mircheva","year":"1995","unstructured":"Mircheva, J, Legendre, C, Soria-Royer, C, Thervet, E, Beaune, P, Kreis, H (1995) Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients. Transplantation 60:639\u2013642","journal-title":"Transplantation"},{"key":"9119_CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V121170","volume":"12","author":"E Thervet","year":"2001","unstructured":"Thervet, E, Anglicheau, D, Toledano, N, Houllier, AM, Noel, LH, Kreis, H, et\u00a0al. (2001) Long-term results of TMPT activity monitoring in azathioprine-treated renal allograft recipients. J Am Soc Nephrol 12:170\u2013176","journal-title":"J Am Soc Nephrol"},{"key":"9119_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s002280100287","volume":"57","author":"N Weyer","year":"2001","unstructured":"Weyer, N, Kroplin, T, Fricke, L, Iven, H (2001) Human thiopurine S-methyltransferase activity in uremia and after renal transplantation. Eur J Clin Pharmacol 57:129\u2013136","journal-title":"Eur J Clin Pharmacol"},{"key":"9119_CR27","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/00007890-199205000-00016","volume":"53","author":"PR Chocair","year":"1992","unstructured":"Chocair, PR, Duley, JA, Simmonds, HA, Cameron, JS (1992) The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 53:1051\u20131056","journal-title":"Transplantation"},{"key":"9119_CR28","first-page":"1298","volume":"27","author":"E Schutz","year":"1995","unstructured":"Schutz, E, Gummert, J, Mohr, FW, Armstrong, VW, Oellerich, M (1995) Azathioprine myelotoxicity related to elevated 6-thioguanine nucleotides in heart transplantation. Transplant Proc 27:1298\u20131300","journal-title":"Transplant Proc"},{"key":"9119_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/clpt.1987.4","volume":"41","author":"L Lennard","year":"1987","unstructured":"Lennard, L, Van Loon, JA, Lilleyman, JS, Weinshilboum, RM (1987) Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 41:18\u201325","journal-title":"Clin Pharmacol Ther"},{"key":"9119_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","volume":"336","author":"L Lennard","year":"1990","unstructured":"Lennard, L, Lilleyman, JS, Van Loon, J, Weinshilboum, RM (1990) Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 336:225\u2013229","journal-title":"Lancet"},{"key":"9119_CR31","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","volume":"85","author":"HL McLeod","year":"1995","unstructured":"McLeod, HL, Relling, MV, Liu, Q, Pui, CH, Evans, WE (1995) Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood 85:1897\u20131902","journal-title":"Blood"},{"key":"9119_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0378-4347(95)00432-7","volume":"678","author":"CW Keuzenkamp-Jansen","year":"1996","unstructured":"Keuzenkamp-Jansen, CW, Leegwater, PA, De Abreu, RA, Lambooy, MA, Bokkerink, JP, Trijbels, JM (1996) Thiopurine methyltransferase: a review and a clinical pilot study. J Chromatogr B Biomed Appl 678:15\u201322","journal-title":"J Chromatogr B Biomed Appl"},{"key":"9119_CR33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2125.1995.tb04478.x","volume":"39","author":"CL Szumlanski","year":"1995","unstructured":"Szumlanski, CL, Weinshilboum, RM (1995) Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. Br J Clin Pharmacol 39:456\u2013459","journal-title":"Br J Clin Pharmacol"},{"key":"9119_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0009-9236(97)90125-9","volume":"62","author":"LD Lewis","year":"1997","unstructured":"Lewis, LD, Benin, A, Szumlanski, CL, Otterness, DM, Lennard, L, Weinshilboum, RM, et\u00a0al. (1997) Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction. Clin Pharmacol Ther 62:464\u2013475","journal-title":"Clin Pharmacol Ther"},{"key":"9119_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/gut.49.5.656","volume":"49","author":"PW Lowry","year":"2001","unstructured":"Lowry, PW, Franklin, CL, Weaver, AL, Szumlanski, CL, Mays, DC, Loftus, EV, et\u00a0al. (2001) Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut 49:656\u2013664","journal-title":"Gut"},{"key":"9119_CR36","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0016-5085(99)70524-X","volume":"116","author":"PW Lowry","year":"1999","unstructured":"Lowry, PW, Szumlanski, CL, Weinshilboum, RM, Sandborn, WJ (1999) Balsalazide and azathioprine or 6-mercaptopurine: evidence for a potentially serious drug interaction. Gastroenterology 116:1505\u20131506","journal-title":"Gastroenterology"},{"key":"9119_CR37","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/00042737-200111000-00006","volume":"13","author":"S Campbell","year":"2001","unstructured":"Campbell, S, Ghosh, S (2001) Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy. Eur J Gastroenterol Hepatol 13:1297\u20131301","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9119_CR38","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1053\/gast.2002.32420","volume":"122","author":"MC Dubinsky","year":"2002","unstructured":"Dubinsky, MC, Yang, H, Hassard, PV, Seidman, EG, Kam, LY, Abreu, MT, et\u00a0al. (2002) 6-MP metabolite profiles provide abiochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 122:904\u2013915","journal-title":"Gastroenterology"},{"key":"9119_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2036.2004.02124.x","volume":"20","author":"J Winter","year":"2004","unstructured":"Winter, J, Walker, A, Shapiro, D, Gaffney, D, Spooner, RJ, Mills, PR (2004) Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther 20:593\u2013599","journal-title":"Aliment Pharmacol Ther"},{"key":"9119_CR40","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1111\/j.1572-0241.2005.41900.x","volume":"100","author":"MC Dubinsky","year":"2005","unstructured":"Dubinsky, MC, Reyes, E, Ofman, J, Chiou, CF, Wade, S, Sandborn, WJ (2005) A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn\u2019s disease treated with azathioprine or 6-mercaptopurine. Am J Gastroenterol 100:2239\u20132247","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9119-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-006-9119-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9119-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9119-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T10:01:08Z","timestamp":1707645668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-006-9119-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,2]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["9119"],"URL":"https:\/\/doi.org\/10.1007\/s10620-006-9119-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,2]]},"assertion":[{"value":"7 September 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}